Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
46.94
+0.18 (0.38%)
At close: Jul 13, 2026
SHA:688192 Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for SHA:688192 stock have an average target of ¥83.00, which predicts a 76.82% increase from the current stock price of 46.94.
Price Target: ¥83.00 (+76.82%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SHA:688192 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 4 | 4 | 4 | 3 |
Financial Forecast
Revenue This Year
1.34B
from 801.14M
Increased by 67.01%
Revenue Next Year
2.09B
from 1.34B
Increased by 56.25%
EPS This Year
-0.58
from -1.89
EPS Next Year
0.71
from -0.58
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.5B | ||
| Avg | 1.3B | ||
| Low | 1.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 90.1% | ||
| Avg | 67.0% | ||
| Low | 44.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.44 | ||
| Avg | -0.58 | ||
| Low | -0.71 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |